NTES Congressional Stock Trades
NetEase, Inc. - American Depositary Shares, each representing 5 ordinary shares (NTES)
Last disclosed trade Apr 6
Every disclosed trade in NTES by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Josh Gottheimer · Bought $NTES · Oct 17 · $1K–$15K
1 other member traded this name in the same window.
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $NTES
Get notified when any member of Congress trades $NTES. Free, no card, no spam.
The record on $NTES
Coldpine has parsed 4 disclosed trades in $NTES by 2 members of Congress, drawn from 4 periodic transaction reports dated Sep 25, 2025 through Apr 6, 2026. All of them came from House members, filed 3 by Democrats and 1 by Republicans.
Of the 4 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 33 days. The longest was 43 days: a $NTES purchase by Josh Gottheimer dated Apr 6, 2026, disclosed May 19, 2026. How late filing is measured across all of Congress is in the late-filers study.
4 of the 4 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Josh Gottheimer filed the most $NTES purchases (2), and Josh Gottheimer the most sales (1).
Members who trade NTES
Recent disclosed trades in NTES
| Date | Member | Type | Amount |
|---|---|---|---|
| Apr 6 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| Mar 5 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Oct 17 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| Sep 25 | Lisa McClain(MI) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →